Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001209191-22-042675

Chief Development Officer sold 11,444 shares at an average $16.01 ($183,271)

  • Chief Development Officer acquired 11,444 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Curley Joanne Chief Development Officer 2022-07-19 Option exercise +5,384 $6.37 $34,311 23,657 D: show line 1 in the form
Curley Joanne Chief Development Officer 2022-07-19 Sale −5,384 $16.02 $86,229 18,273 D: show line 2 in the form
Curley Joanne Chief Development Officer 2022-07-19 Option exercise +6 $6.37 $38 18,279 D: show line 3 in the form
Curley Joanne Chief Development Officer 2022-07-19 Sale −6 $16.55 $99 18,273 D: show line 4 in the form
Curley Joanne Chief Development Officer 2022-07-19 Option exercise +6,046 $2.90 $17,514 24,319 D: show line 5 in the form
Curley Joanne Chief Development Officer 2022-07-19 Sale −6,046 $16.01 $96,810 18,273 D: show line 6 in the form
Curley Joanne Chief Development Officer 2022-07-19 Option exercise +8 $2.90 $23 18,281 D: show line 7 in the form
Curley Joanne Chief Development Officer 2022-07-19 Sale −8 $16.55 $132 18,273 D: show line 8 in the form
Open-market sales · 11,444 sh · avg $16.01 · $183,271

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Curley Joanne Chief Development Officer 2022-07-19 Option exercise · Stock Option (right to buy) −5,390 14,029 D: show line 9 in the form
Curley Joanne Chief Development Officer 2022-07-19 Option exercise · Stock Option (right to buy) −6,054 46,759 D: show line 10 in the form
Loading xslF345X03/doc4.xml…